Medicare

GLP-1 medications have expanded treatment options for Americans struggling with obesity, but affordability remains a major concern. Prices vary depending on the medication, dosage, insurance coverage, and available savings programs. Fortunately, manufacturer discounts and public insurance initiatives offer potential ways to reduce expenses. Understanding key options can help patients find medically appropriate treatment without facing […]